TREATMENT · ARTERIAL · ARTERIAL · TARGETED ONCOLOGY
Chemo-embolization and radio-frequency ablation that target the tumor — not the whole body.
Liver tumors — primary liver cancer or secondaries — can be treated through their own blood supply. Trans-arterial chemo-embolization (TACE) delivers chemotherapy directly into the artery feeding the tumor and then blocks it; radio-frequency ablation (RFA) destroys smaller tumors with precise heat through a needle. Healthy liver is spared, and side effects are far milder than systemic chemotherapy.
Scans and blood tests decide whether TACE, RFA or a combination fits your tumor stage.
A 2 mm entry at the wrist or groin; a microcatheter navigates to the tumor's feeding artery.
Chemotherapy-loaded particles go into the tumor and its blood supply is blocked (TACE) — or a needle ablates it with heat (RFA).
A short stay, then scans track the tumor's response. Sessions are repeated if needed.
Systemic chemotherapy circulates through the whole body. TACE concentrates the drug inside the tumor itself and blocks the artery feeding it — higher local dose, far fewer whole-body side effects.
Some fever, fatigue and right-sided discomfort for a few days (post-embolisation syndrome) is common and settles with simple medication.
For selected small tumors, ablation can be curative. More often TACE controls the disease, downstages it for surgery or transplant, or holds it alongside other treatment. Your stage decides — we will be straightforward about the goal.
Bring your scans and reports, or send them on WhatsApp first. One consultation answers most of your questions.
Flow Vascular Clinic — 2nd Floor, Sree Krishna Diagnostic Center Building, beside Kalamandir, KPHB Main Road, Kukatpally, Hyderabad 500072